Impact of antiretroviral drugs in pregnant women and their children in africa: HIV resistance and treatment outcomes

Roger Paredes, Vincent C. Marconi, Shahin Lockman, Elaine J. Abrams, Louise Kuhn

Research output: Contribution to journalArticleResearchpeer-review

38 Citations (Scopus)

Abstract

The global community has committed itself to eliminating new pediatric HIV infections by 2015 and improving maternal, newborn, and child health and survival in the context of HIV. Such objectives require regimens to prevent mother-to-child transmission (pMTCT) which, while being highly efficacious, protect the efficacy of future first-line antiretroviral therapy (ART). Major obstacles to eliminating vertical transmissions globally include low rates of adherence to ART and non-completion of the 'pMTCT cascade' due to programmatic and structural challenges faced by healthcare systems in low-income countries. Providing all pregnant women with lifelong ART regardless of CD4 count/disease stage (Option B+) could be the most effective option to prevent both HIV transmission and resistance, assuming adherence is successfully maintained. This strategy is more likely to achieve sustained undetectable HIV viremia, does not involve ART interruptions, is simpler to implement, and is cost-effective. Where Option B+ is not available, options A (short course zidovudine with single-dose nevirapine and an ARV "tail") and B (combination ART during pregnancy and breastfeeding, with ART cessation after weaning in women not qualifying for ART for their own health) are also efficacious, highly cost-effective and associated with infrequent resistance selection if taken properly. © The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
Original languageEnglish
JournalJournal of Infectious Diseases
Volume207
Issue numberSUPPL.2
DOIs
Publication statusPublished - 15 Jun 2013

Keywords

  • antiretroviral therapy
  • HIV
  • mother-to-child transmission
  • prophylaxis
  • resistance

Fingerprint

Dive into the research topics of 'Impact of antiretroviral drugs in pregnant women and their children in africa: HIV resistance and treatment outcomes'. Together they form a unique fingerprint.

Cite this